Newport Asia Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WX
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
|
+$30.1M |
| 2 |
Alibaba
BABA
|
+$10.4M |
| 3 |
Baidu
BIDU
|
+$7.78M |
| 4 |
LFC
China Life Insurance Company Ltd.
LFC
|
+$1.62M |
| 5 |
Sony
SONY
|
+$361K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trip.com Group
TCOM
|
+$16M |
| 2 |
NetEase
NTES
|
+$374K |
| 3 |
Huazhu Hotels Group
HTHT
|
+$330K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 74.73% |
| 2 | Consumer Discretionary | 14.35% |
| 3 | Healthcare | 10.52% |
| 4 | Technology | 0.12% |
| 5 | Financials | 0.1% |
Similar funds
Newport Asia's Q2 2015 Portfolio in Review
As of Q2 2015, Newport Asia held 9 positions worth $288M, up 13% from $255M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Newport Asia deployed $33.8M of net new capital in Q2 2015, opening 3 new positions and adding to 3 existing holdings. Its largest new stake was WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS: 714,600 shares worth $30.3M.
By sector, the portfolio is most concentrated in Communication Services at 75% of assets, down from 78% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NetEase, an estimated $374K trimmed.
- Newport Asia's largest Q2 2015 buy was WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS: 714,600 shares worth $30.3M.
- Newport Asia added most to Alibaba in Q2 2015, an estimated $10.4M increase.
- Newport Asia's biggest Q2 2015 reduction was NetEase, cutting an estimated $374K.
- Newport Asia fully exited Trip.com Group in Q2 2015, selling an estimated $16M.
- Newport Asia's ten largest holdings make up 100% of its $288M portfolio in Q2 2015.
- Newport Asia opened 3 new positions and closed 2 in Q2 2015.
- Newport Asia's portfolio value rose 13% quarter-over-quarter to $288M.
Based on Newport Asia's 13F filing for Q2 2015, filed 4 Aug 2015.